Difficulty: Medium
Average Score: 93%
Practice
Indicate the second-generation heterocyclic drug:
Correct answer
A
Rationale
The correct answer is A) Maprotiline, which is a second-generation heterocyclic drug. Maprotiline belongs to the tetracyclic antidepressants class of drugs and is commonly used in the treatment of depression.
Imipramine (option B) is a first-generation tricyclic antidepressant, not a second-generation heterocyclic drug. It is used in the treatment of various psychiatric conditions, including depression and enuresis.
Phenelzine (option C) is a monoamine oxidase inhibitor (MAOI), which is a different class of antidepressant drugs compared to second-generation heterocyclic drugs like Maprotiline.
Fluoxetine (option D) is a selective serotonin reuptake inhibitor (SSRI), which is also a different class of antidepressant drugs compared to Maprotiline.
Understanding the classification of antidepressant drugs is crucial for healthcare professionals, especially in pharmacology practice. Knowing the differences between drug classes helps in selecting the most appropriate medication for patients based on their condition, comorbidities, and potential side effects. This knowledge is essential for safe and effective medication management in patients across the lifespan.
Imipramine (option B) is a first-generation tricyclic antidepressant, not a second-generation heterocyclic drug. It is used in the treatment of various psychiatric conditions, including depression and enuresis.
Phenelzine (option C) is a monoamine oxidase inhibitor (MAOI), which is a different class of antidepressant drugs compared to second-generation heterocyclic drugs like Maprotiline.
Fluoxetine (option D) is a selective serotonin reuptake inhibitor (SSRI), which is also a different class of antidepressant drugs compared to Maprotiline.
Understanding the classification of antidepressant drugs is crucial for healthcare professionals, especially in pharmacology practice. Knowing the differences between drug classes helps in selecting the most appropriate medication for patients based on their condition, comorbidities, and potential side effects. This knowledge is essential for safe and effective medication management in patients across the lifespan.